Sfoglia per Autore
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties
2026 Shaik, M; Ami, D; Romerio, A; Gagliano, C; Palmer, C; Aladailleh, Z; Mitchell, E; Chavez, J; Zain, A; Farris, S; Gaboardi, M; Natalello, A; Pirianov, G; Peri, F
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives
2026 Lami, F; Romerio, A; Valle-Gomez, L; Martin-Camara, O; Martin-Santamaria, S; Peri, F
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants
2025 Romerio, A; Shaik, M; Italia, A; Lami, F; Galimberti, M; Peri, F
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
2025 Shirey, K; Romerio, A; Shaik, M; Leake, D; Palmer, C; Skupinska, N; Paton, J; Pirianov, G; Blanco, J; Vogel, S; Peri, F
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists
2025 Franco, A; Aladailleh, Z; Romerio, A; Italia, A; Lami, F; Shaik, M; Skupinska, N; Artusa, V; Pirianov, G; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2025 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts
2025 Italia, A; Romerio, A; Lami, F; Sarcinelli, G; Lenoci, M; Galli, M; Granucci, F; Costa, B; Lovisa, S; Peri, F
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge
2025 Sainz-Mejias, M; Ma, C; Hou, Y; Jurado-Martin, I; Romerio, A; Franco, A; Shaik, M; Tomas-Cortazar, J; Peri, F; Mcclean, S
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants
2024 Romerio, A; Shaik, M; Italia, A; Lami, F; Peri, F
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators
2024 Romerio, A; Shaik, M; Italia, A; Peri, F
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists
2024 Lami, F; Romerio, A; Italia, A; Shaik, M; Martin-Santamaria, S; Peri, F
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists
2024 Ami, D; Franco, A; Artusa, V; Romerio, A; Shaik, M; Italia, A; Anguita, J; Pasco, S; Mereghetti, P; Peri, F; Natalello, A
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies
2024 Franco, A; Sadones, O; Romerio, A; Artusa, V; Shaik, M; Pasco, S; Italia, A; D'Amato, S; Anguita, J; Huebner, J; Romero-Saavedra, F; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2024 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant
2024 Shaik, M; Pasco, S; Romerio, A; Pifferi, C; Sesana, S; Re, F; Bezuidenhout, C; Bracco, S; Fernandez-Tejada, A; Anguita, J; Peri, F
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants
2023 Romerio, A
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS
2023 Romerio, A; Franco, A; Artusa, V; Shaik, M; Lami, F; Peri, F
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators
2023 Romerio, A; Franco, A; Shaik, M; Lami, F; Benivegna, G; Scalvini, S; Peri, F
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives
2023 Musumeci, R; Martinelli, M; Giubbi, C; Perdoni, F; Romerio, A; Vertemara, J; De Gioia, L; Peri, F; Cocuzza, C
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile